energy-investing Cameco announces third quarter results: financial performance on track for strong finish to the year; nuclear fundamentals strengthened by transformational partnership to deploy Westinghouse reactors in the US; annual dividend declared
energy-investing Cameco and Brookfield Establish Transformational Partnership With United States Government to Accelerate Deployment of Westinghouse Nuclear Reactors
energy-investing Cameco Provides Production Update; Strategically Well-Positioned for Continued Long-Term Value Creation
energy-investing Cameco Q2 results: strong financial performance reflecting positive momentum for nuclear power; uranium average realized price benefitting from long-term contracting strategy; Westinghouse opportunities driving improved 2025 outlook
energy-investing Cameco Reports Q1 Results: Strong Consolidated Financial and Operational Results; Average Realized Price Benefitting From Long-Term Contracting Strategy; Full-Cycle Market Fundamentals Remain Positive
Cameco and Energoatom Agree on Commercial Terms to Supply Ukraine's Full Natural UF6 Needs through 2035
FDA Accepts LEQEMBI® IQLIK Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
FDA Accepts LEQEMBI® IQLIKTM Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
CORRECTION - Domestic Metals Engages ICP Securities Inc. for Automated Market Making Services and provides further details on the engagement of Michael Pound
